NDC 45802-078
BRIMONIDINE
Brimonidine
BRIMONIDINE is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is Brimonidine Tartrate.
| Product ID | 45802-078_a2c74527-fc36-4141-a382-02fb06d6c0c8 |
| NDC | 45802-078 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BRIMONIDINE |
| Generic Name | Brimonidine |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2023-01-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA209158 |
| Labeler Name | Padagis Israel Pharmaceuticals Ltd |
| Substance Name | BRIMONIDINE TARTRATE |
| Active Ingredient Strength | 5 mg/g |
| Pharm Classes | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |